These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1550872)

  • 1. Tissue damage caused by TNF and complement.
    Rothstein JL; Schreiber H
    Immunol Ser; 1992; 56():453-81. PubMed ID: 1550872
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin.
    Hsueh W; Sun X; Rioja LN; Gonzalez-Crussi F
    Immunology; 1990 Jul; 70(3):309-14. PubMed ID: 2379939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selection of a cell line for resistance to lysis by tumor necrosis factor-alpha selects for reduced tumorigenicity.
    Patek PQ; Lin Y
    J Immunol; 1991 May; 146(10):3457-61. PubMed ID: 2026874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation by bacterial endotoxin.
    Burrell R
    Crit Rev Microbiol; 1990; 17(3):189-208. PubMed ID: 1689164
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice.
    Sun XM; Hsueh W
    J Immunol; 1991 Jul; 147(2):509-14. PubMed ID: 2071893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour necrosis factor triggers granulocytes to internalize complement-coated virus particles.
    van Strijp JA; van der Tol ME; Miltenburg LA; van Kessel KP; Verhoef J
    Immunology; 1991 May; 73(1):77-82. PubMed ID: 1646162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
    Hori K; Ehrke MJ; Mace K; Maccubbin D; Doyle MJ; Otsuka Y; Mihich E
    Cancer Res; 1987 Jun; 47(11):2793-8. PubMed ID: 2882835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic damage of tumor vessels with ultra low-dose endothelial-monocyte activating polypeptide-II and neovasculature-targeted tumor necrosis factor-alpha.
    Crippa L; Gasparri A; Sacchi A; Ferrero E; Curnis F; Corti A
    Cancer Res; 2008 Feb; 68(4):1154-61. PubMed ID: 18281491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor necrosis factor (TNF)--its biochemical characteristics and biological properties].
    Skotnicki AB; Rucińska M
    Przegl Lek; 1989; 46(10):736-43. PubMed ID: 2594993
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
    Hori K; Mihich E; Ehrke MJ
    Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF in the inflammatory response.
    Männel DN; Echtenacher B
    Chem Immunol; 2000; 74():141-61. PubMed ID: 10608086
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antitumor activity of tumor necrosis factor (TNF) in vitro and in vivo].
    Haranaka K; Satomi N; Sakurai A
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1387-93. PubMed ID: 6742865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cytotoxicity of rat alveolar macrophages activated in vitro by endotoxin.
    Sone S; Fidler IJ
    J Reticuloendothel Soc; 1980 Mar; 27(3):269-79. PubMed ID: 7365733
    [No Abstract]   [Full Text] [Related]  

  • 15. Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions.
    Scallon BJ; Moore MA; Trinh H; Knight DM; Ghrayeb J
    Cytokine; 1995 Apr; 7(3):251-9. PubMed ID: 7640345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of iron in the cytotoxicity of tumor necrosis factor.
    Warren S; Torti SV; Torti FM
    Lymphokine Cytokine Res; 1993 Apr; 12(2):75-80. PubMed ID: 8324080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological mediators.
    Christou NV; Tellado-Rodriguez J
    Prog Clin Biol Res; 1988; 264():115-24. PubMed ID: 3289017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoproterenol inhibits bacterial lipopolysaccharide-stimulated release of tumor necrosis factor-alpha from human heart tissue.
    Smart KR; Warejcka DJ; Castresana MR; Dalton ML; Webb JG; Newman WH
    Am Surg; 2000 Oct; 66(10):947-51. PubMed ID: 11261622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage tumor necrosis factor-alpha release is induced by contact with some tumors.
    Hasday JD; Shah EM; Lieberman AP
    J Immunol; 1990 Jul; 145(1):371-9. PubMed ID: 2358679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
    Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.